Scientists investigate immune cell role in rare IgG4 disease
NCT ID NCT02899039
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at a rare disease called IgG4-related disease, which causes swelling and scarring in organs. Researchers compared immune cells in the blood of 75 people: those with the disease, those with Sjogren syndrome, and healthy volunteers. The goal was to better understand how certain T cells might be involved in the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could improve understanding of IgG4-related disease and point toward new ways to diagnose or monitor it.
- What could go wrong
- This is an observational study, not a treatment trial. It is small (75 participants) and may not lead to direct clinical benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGG4-RELATED DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APHM
Marseille, 13, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New eye drops aim to calm Sjögren's dry eye by blocking inflammation
- New drug aims to stop IgG4 disease relapses without Long-Term steroids
- Experimental CAR-T injection aims to tame autoimmune diseases
- Old drug, new hope: could filgotinib tame rare immune diseases?
- New scan could shine a light on hidden inflammation
- New hope for Sjögren's fatigue: acupuncture and nerve zaps join exercise in clinical trial